Session 4 "Advanced manufacturing of gene therapeutics" | |
---|---|
09:00 |
KEYNOTE LECTURE Advancement of Viral Delivery Systems Manufacturing Processes Remains Critical to the Success of Cell and Gene Therapy A. Kamen, McGill University, Montreal/CAN |
09:45 |
An automated process for lentiviral transduction of CD34+ cells in a GMP-compliant closed system E. Papanikolaou, Miltenyi Biotec GmbH, Bergisch Gladbach/D |
10:10 |
New level of integrity assurance at point of use and cryogenic robustness of single use systems for cell & gene therapy J. Kirchmair, Single Use Support GmbH, Kufstein/A |
10:35 |
Downstream Purification Solutions for Viral Vectors: Enabling Platform Approaches to Advance Cell and Gene Therapy F. Detmers, ThermoFisher Scientific, Leiden/NL |
11:00 |
Poster Talk: Tentacle-based ion exchange chromatography for purification of viral vectors M. Schulte, Merck KGaA, Darmstadt/D |
11:15 | COFFEE BREAK |
Session 5 "Production of gene therapeutics for clinical application" | |
11:45 |
KEYNOTE Towards intensified/optimized large scale production of viral vectors O. Merten, Miltenyi Biotec Europe GmbH, Paris/F |
12:30 |
KEYNOTE Liver-based AAV Gene Therapy for Curative Treatments M. Hörer, Freeline Therapeutics GmbH, Planegg-Steinkirchen/D |
13:15 | LUNCH |
Session 6 "Regulatory pathways to enable gene therapy" | |
14:15 |
KEYNOTE LECTURE Development and Regulation of Gene Therapy Medicinical Products K. Cichutek, Paul-Ehrlich-Institut, Langen/D |
15:00 |
Gene Therapy in Point-of-Care Settings - from Adult Stem Cell Therapy to Germline Mitochondria Therapy: Missing Legal Therapy and Market Control? T. Faltus, Martin-Luther-Universität Halle-Wittenberg, Halle (S.)/D |
15:25 |
Regulatory, Clinical and Logistics Challenges of Cell & Gene Therapy Trials The CRO Perspective A. Zobel, PAREXEL International GmbH, Berlin/D |
15:50 | COFFEE AND NETWORKING |
16:15 | END OF CONFERENCE |
Please click here to see the conference programm of 30 January 2019
Please click here to see the poster programme